Share Prices & Company Research

Stockbroking

Dechra Pharmaceuticals

Current Price 2752.00p Bid 2720.00p Ask 2726.00p Change -0.87%
Last Updated: 27/05/2018 16:37. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Dechra Pharmaceuticals plc is an international specialist veterinary pharmaceuticals and relates products business. Its expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.

Financial Highlights Year Ended 30/06/2017

Turnover
£359.28m
Operating Profit
£33.21m
Dividend Yield
0.84
Dividend Per Share
21.44
Dividend Cover
1.24
P/E Ratio
96.48

Key Personnel

Ian David Page
Chief Executive
Richard John Cotton
Chief Financial Officer
Anthony Gerard Griffin
Executive Director
William Anthony Rice
Non-Executive Chairman
Dr Lawson Macartney
Non-Executive Director
Julian Spenser Heslop
Non-Executive Director
Ishbel Jean Stewart Macpherson
Non-Executive Director

Stock Details

EPIC
DPH
ISIN
GB0009633180
Shares in Issue
102,326,635
Market cap
£2,773.05m

Analyst Views (3)

Strong Buy
 
33.33%
Buy
 
33.33%
Hold
 
33.33%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
2720.00p
Bid Price
2720.00p
Ask Price
2726.00p
Volume
296566
Change Today
-24.00p
% Change Today
-0.87%
Open
2750.00p
Previous Close
2720.00p
Intraday High
2772.00p
Intraday Low
2720.00p
52 Week High
2840.00p
52 Week Low
1636.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Dechra Pharmaceuticals Intra-day Chart

Dechra Pharmaceuticals News

News in this section is provided by MoneyAM

Director Deals - Dechra Pharmaceuticals PLC (DPH) 05 Mar 2018 | 12:30 Director Deals - Dechra Pharmaceuticals PLC (DPH) 26 Feb 2018 | 17:30 Major stock markets enjoy positive start to the week 26 Feb 2018 | 16:53 FTSE follows Asia with bright start to the week 26 Feb 2018 | 11:57 Dechra Pharmaceuticals revenue grows 11.2% amid strong performance in North America 26 Feb 2018 | 10:08 Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLC 02 Feb 2018 | 12:40 Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC 30 Jan 2018 | 09:10 Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC 17 Jan 2018 | 13:50 Festive cheer for Morrisons supports firm FTSE 09 Jan 2018 | 16:45 Upbeat trading at Morrison's lifts grocery stocks 09 Jan 2018 | 11:23 Dechra sees double-digit revenue growth 09 Jan 2018 | 08:20 Dechra sees continued growth across all markets 20 Oct 2017 | 07:06 Director Deals - Dechra Pharmaceuticals PLC (DPH) 20 Sep 2017 | 17:05 Director Deals - Dechra Pharmaceuticals PLC (DPH) 20 Sep 2017 | 17:05 Director Deals - Dechra Pharmaceuticals PLC (DPH) 19 Sep 2017 | 14:55 Director Deals - Dechra Pharmaceuticals PLC (DPH) 19 Sep 2017 | 14:55 Broker Forecast - Cantor Fitzgerald issues a broker note on Dechra Pharmaceuticals PLC 08 Sep 2017 | 08:40 Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLC 05 Sep 2017 | 11:00 Director Deals - Dechra Pharmaceuticals PLC (DPH) 04 Sep 2017 | 16:00 Dechra growth driven by core portfolio 06 Jul 2017 | 08:17 FLASH: Dechra growth driven by core portfolio 06 Jul 2017 | 07:05 Director Deals - Dechra Pharmaceuticals PLC (DPH) 22 Jun 2017 | 11:50

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2017
30 Jun 2016
Tangible Assets
45.2
37.7
Intangible Assets & Goodwill
396.3
360.4
Investments & Other Non-Current Assets
11.6
0.2
Total Non-Current Assets
453.1
398.3
Inventory
56.5
54.4
Trade & Receivables
67.3
68.9
Cash & Receivables
61.2
39.1
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
638.1
560.8

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2017
30 Jun 2016
Short Term Liabilities
66.4
66.3
Long Term Liabilities
269.0
217.9
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
335.4
284.1

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2017
30 Jun 2016
Net Assets
302.6
276.6

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2017
30 Jun 2016
Share Capital
0.9
0.9
Minority Interests
1.6
2.0
Retained Earnings
107.4
94.0
Share Premium Account
173.4
172.5
Other Equity
19.3
7.3
Total Equity
302.6
276.6

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2017
30 Jun 2016
Cashflow from Operating Activities
77.4
43.6
Cashflow Before Financing
20.2
-130.5
Increase / Decrease in Cash
21.7
-5.2

Income (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2017
30 Jun 2016
Turnover
359.3
247.6
Cost of Sales
167.6
115.1
Gross Profit
191.7
132.4
Operating Profit
33.2
19.5
Pre-Tax Profit
28.6
14.6
Profit / Loss for the Year
26.1
12.5

Dividend History

Data has been provided by MoneyAM

Period
Ex-Dividend Date
Payment Date
H1 Dividend
08 Mar 2018
06 Apr 2018
H2 Dividend
26 Oct 2017
17 Nov 2017
H1 Dividend
09 Mar 2017
07 Apr 2017
H2 Dividend
27 Oct 2016
18 Nov 2016
H1 Dividend
10 Mar 2016
06 Apr 2016
H2 Dividend
29 Oct 2015
20 Nov 2015
H1 Dividend
12 Mar 2015
07 Apr 2015
H2 Dividend
06 Nov 2014
21 Nov 2014
H1 Dividend
12 Mar 2014
08 Apr 2014
H2 Dividend
06 Nov 2013
22 Nov 2013
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.